Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1212 of 6351
-
Epigenetic drugs aim to stop cancer return after transplant in kids
Disease control OngoingThe objective of this study is to evaluate the maximum tolerated (MTD) of vorinostat used in combination with low-dose azacitidine after allogeneic hematopoietic cell transplantation (alloHCT) for prevention of relapse of childhood myeloid malignancies.
Phase 1 • Sponsor: Johns Hopkins All Children's Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New study challenges safety of keyhole surgery for cervical cancer
Disease control OngoingCervical cancer is the most common cause of death from gynecological cancer world-wide. With technological innovation, minimally invasive or even non-invasive medical treatment has become a trend. Since the first cases of laparoscopic radical hysterectomy of cervical cancer have …
Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope for kids on dialysis: drug targets hormone imbalance
Disease control Recruiting nowThis is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) on hemodialysis.
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Robot therapy could speed stroke recovery in first months
Symptom relief Recruiting nowEarly after stroke, patients often have significant motor impairment and sensory deficit. Evidence has demonstrated heightened plasticity and significant recovery in the acute phase (first months) post stroke but there has been a lack of effective and practical protocols and devi…
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Cancer drug shows promise for treating lewy body dementia
Disease control CompletedThis study evaluates the effect of Bosutinib (Bosulif,Pfizer®) in the treatment of patients with Dementia with Lewy Bodies. Half participants will receive 100 mg of Bosutinib , while the other half will receive placebo.
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Immunotherapy combo tested for aggressive breast cancer – trial stopped early
Disease control Stopped earlyThis randomized phase III trial studies how well paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab works in treating patients with breast cancer that has spread to other parts of the body (metastatic). Chemotherapy drugs, such as paclitaxel, work in different w…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo shot may slash opioid use after hernia repair
Symptom relief CompletedThis is a Phase 3b, open-label study to assess postoperative opioid use in subjects undergoing unilateral open inguinal herniorrhaphy with intraoperative administration of HTX-011 and a postoperative non-opioid multimodal analgesic (MMA) regimen. The study will be conducted in 2 …
Phase 3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Could a low protein diet keep kidneys working longer?
Disease control Recruiting nowNephrology care continues to progress and recommendations are now focused on delaying as much as possible the need for renal replacement therapy ("intent-to-defer"strategy). Protein restriction is a valuable tool for stabilizing chronic kidney disease (CKD) and retarding the need…
Sponsor: Centre Hospitalier le Mans • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug bimekizumab shows promise for psoriatic arthritis in phase 3 trial
Disease control CompletedThis is a study to demonstrate the clinical efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared with placebo in the treatment of tumor necrosis factor alpha-inadequate responders (TNFα-IR) subjects with active Psoriatic Arthritis (PsA).
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Eye implant could offer long-term pressure control for glaucoma patients
Disease control CompletedThis study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hypertension who completed 1 of the 4 Phase 3 Bimatoprost SR studies (192024-091, -092, -093, or -095) and received Bimatoprost SR or wh…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug cocktail shows promise for tough head and neck cancers
Disease control CompletedThis proof-of-concept study aims to assess the clinical and biological effects of Atezolizumab combined with Bevacizumab in advanced previously treated squamous-cell carcinoma of the head and neck (HNSCC).
Phase 2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Gene study aims to boost kidney transplant success for african americans
Knowledge-focused OngoingThe APOLLO study is being done in an attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation based upon variation in the apolipoprotein L1 gene (APOL1). Genes control what is inherited from a family, such as eye color or blood …
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New anthrax vaccine shows promise in large trial
Vaccine CompletedThis study is designed to evaluate the lot consistency (using three consecutively manufactured lots), safety, and ability of the AV7909 anthrax vaccine to generate an immune response in healthy adults and compare the response to that induced by the currently licensed vaccine, Bio…
Phase 3 • Sponsor: Emergent BioSolutions • Aim: Vaccine
Last updated Jun 27, 2026 12:29 UTC
-
Could a common diabetes drug ease a type of heart failure?
Disease control CompletedThe main objective of this study is to determine the clinical efficacy of metformin versus placebo and the therapeutic response with regards to functional capacity and hemodynamics in PH-HFpEF.
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for mystery cancers: immunotherapy shows promise
Disease control CompletedAbbreviated Title : CUPem Clinical Indication : A Phase II, Two-Stage, Trial of Pembrolizumab in Cancer of unknown primary Trial Type : Single Arm, non-randomised; Two-stage; Hypothesis generating Type of control : None Route of administration : IV Trial Blinding : N/A Treatment…
Phase 2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a tiny shock absorber in the knee replace the need for joint replacement?
Symptom relief CompletedA study to evaluate the safety and effectiveness of the Calypso Knee System when used in subjects with symptomatic osteoarthritis of the medial compartment of the knee.
Sponsor: Moximed • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can psoriasis patients skip more shots? new trial tests extended guselkumab dosing
Disease control CompletedThe purpose of this study is to demonstrate that Super-Responders (SRe; defined as psoriasis participants who receive on-label guselkumab treatment until week 20 and respond with a Psoriasis Area and Severity Index score (PASI) = 0 at weeks 20 and 28) maintain control of disease …
Phase 3 • Sponsor: Janssen-Cilag International NV • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Targeted chemotherapy pump takes fight directly to pancreatic cancer liver tumors
Disease control OngoingThis is a single arm, phase II study without blinding. The purpose is to determine the impact of hepatic artery infusion Floxuridine (FUDR) on liver metastases from pancreatic adenocarcinoma. Patients at Spectrum Health will receive standard of care chemotherapy. They will also r…
Phase 2 • Sponsor: Corewell Health West • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can MRI outsmart blood tests for prostate cancer?
Diagnosis Recruiting nowThe commercialization of MRI fusion biopsies has resulted in a dramatic increase in the use of MRI imaging for prostate cancer. How best to use MRI in the initial prostate biopsy setting given the availability of validated prostate cancer early detection markers is uncertain.This…
Sponsor: University of Michigan • Aim: Diagnosis
Last updated Aug 19, 2026 00:00 UTC
-
Can a vaccine keep TB away for good? new study tests H56:IC31
Vaccine CompletedThis is a phase 2, double-blind, randomized (1:1), placebo-controlled trial with two parallel groups. * H56:IC31 (investigational vaccine) * Placebo 900 HIV-negative adults with a diagnosis of drug susceptible pulmonary TB are planned to be included, recruited from TB clinics…
Phase 2 • Sponsor: International AIDS Vaccine Initiative • Aim: Vaccine
Last updated Jun 27, 2026 09:07 UTC